Cercar
01/02/2023
Pathophysiology of Chronic Bronchial Infection in Bronchiectasis
Solarat, B, Perea, L, Faner, R, de la Rosa, D, Martinez-Garcia, MA, Sibila, O. Pathophysiology of Chronic Bronchial Infection in Bronchiectasis. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(2)DOI:10.1016/j.arbres.2022.09.004. PMID:36180278. IF:8.700(Q1/1D).
01/01/2023
Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
Crespo-Lessmann A., Curto E., Medina, EFM, Palones E., Soler A.B., Maza S.S., Soto-Retes L., Plaza V.. Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia. Journal of Asthma and Allergy. 2023; 16DOI:10.2147/JAA.S389402. PMID:36699564. IF:3.700(Q1/3D).
01/01/2023
Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
Molina J., Plaza V., Nuevo J., Gutiérrez M., Sicras-Mainar A., Valero A.. Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100232. PMID:37496866. IF:(Q/D).
01/01/2023
Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
Plaza V., Cañete C., Domingo C., Martínez Rivera C., Muñoz X.. Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2022.100231. PMID:37496871. IF:(Q/D).